Clarivate (NYSE:CLVT) is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.
Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction. Since its founding, the company has expanded its portfolio through strategic acquisitions, including ProQuest, which broadened its reach into academic libraries and scholarly publishing, as well as Derwent, Cortellis, Techstreet and other brands that enhance its capabilities in patent analytics, scientific literature search and standards management.
Headquartered in London, with significant operations in North America—where its U.S. headquarters is located in Philadelphia—Clarivate serves more than 50,000 customers in over 150 countries. Its platforms, such as Web of Science, ScholarOne, and MarkMonitor, are widely used by researchers, patent professionals and brand managers to discover insights, protect innovations and make data-driven decisions across the research lifecycle.
Under the leadership of Chairman and CEO Jerre Stead, Clarivate continues to invest in artificial intelligence and machine-learning technologies to enhance its analytics offerings. The company emphasizes collaboration with academic institutions, corporate R&D departments and government agencies to support innovation, streamline intellectual property processes and accelerate the journey from discovery to market.
